CReATe Consortium and American Brain Foundation Clinical Research Award
Supports early-career clinical research on ALS, ALS-FTD, PLS, PMA, and HSP to advance understanding, diagnosis, and treatment of these neurodegenerative diseases.
Funder: American Academy of Neurology
Due Dates (Anticipated): June 2027 (Full application deadline, projected)
Funding Amounts: Typically $65,000/year for 2 years plus $10,000/year stipend; total award up to $150,000.
Summary: Supports young investigators conducting clinical research on ALS, ALS-FTD, PLS, PMA, and HSP to advance understanding and treatment of these neurodegenerative diseases.
Key Information: Award will not be offered in 2026; next anticipated cycle is 2027.
Description
This award supports early-career investigators engaged in clinical research on neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), ALS-frontotemporal dementia (ALS-FTD), primary lateral sclerosis (PLS), progressive muscular atrophy (PMA), and hereditary spastic paraplegia (HSP). The goal is to encourage innovative clinical studies that advance the understanding, diagnosis, and treatment of these conditions, ultimately aiming to improve patient outcomes and contribute to the broader field of neurology.
